<DOC>
	<DOCNO>NCT02144259</DOCNO>
	<brief_summary>This prospective mixed method study assess weight change woman randomize receive Implanon ® Depo Provera® ( DMPA ) immediately postpartum compare woman choose non-hormonal contraception contraception immediately postpartum . After enrollment , subject return visit 3 , 6 12 month postpartum ask series question , take pregnancy test , weigh . Total length participation subject 1 year pregnancy .</brief_summary>
	<brief_title>The Impact Contraception Postpartum Weight Loss</brief_title>
	<detailed_description />
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<criteria>English speaking Aged 1845 enrollment ( inclusive ) Immediately postpartum live singleton infant , 37 week gestation , HUP Desiring delay another pregnancy 6 month Willing able follow study protocol Breastfeeding study participation Plans relocation outside Philadelphia next six month Plans use weight loss medication diet pill next six month Women wish start Implanon ® DMPA prior discharge want randomize . 5 . Issues concern judgment investigator may compromise safety subject confound reliability compliance information acquire study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>